Mark Wegter
InvestorPartner at EQT Life Sciences · Director at Kennet Partners
Amsterdam, Netherlands
Writes $2.2M – $54M checks · typically $25M
About
Mark Wegter keeps a low public profile, preferring behind-the-scenes, governance-heavy, board-focused investing rooted in deep experience as a director and a background in traditional European private equity and growth capital.
Contact· self-published, not guessed
Invests in
AI & Machine LearningClimate TechFintechSaaSSpace Tech
Deals · 1
Kiadis Pharma N.VBoard seat
via EQT Life Sciences · filed Jun 2019 · $18.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at EQT Life Sciences
Alex Darden
Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Chris Stone
Investor at EPIC VENTURES
Christina Drews
Chief Operating Officer at EQT Life Sciences
Frequently asked questions
- Who is Mark Wegter?
- Mark Wegter keeps a low public profile, preferring behind-the-scenes, governance-heavy, board-focused investing rooted in deep experience as a director and a background in traditional European private equity and growth capital.
- Where does Mark Wegter work?
- Mark Wegter is Partner at EQT Life Sciences.
- What does Mark Wegter invest in?
- Mark Wegter invests in AI & Machine Learning, Climate Tech, Fintech, SaaS, Space Tech.
- What check size does Mark Wegter write?
- Mark Wegter typically writes checks of $2.2M – $54M.
- What boards does Mark Wegter sit on?
- Mark Wegter holds tracked board seats at Kiadis Pharma N.V.